Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cosmetic gel added to minoxidil or finasteride for androgenetic alopecia
ISRCTN10404684Phase 4Completed
- Sponsor
- Cantabria Labs
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of minoxidil and finasteride in androgenetic alopecia (AGA) and Female Pattern Hair Loss (FPHL) (4 arms), sponsored by Cantabria Labs. Primary endpoints: Global Photographic Assessment Score improvement and Blinded photographic assessment over time. Started Jan 2021; status: completed.
02
Drugs
minoxidilfinasteride
03
Conditions
androgenetic alopecia (AGA)Female Pattern Hair Loss (FPHL)
Beyond the preview
Go deeper on ISRCTN10404684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10404684.